Related Experiment Video
Updated: Jan 24, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Marine-Derived Anticancer Agents: Clinical Benefits, Innovative Mechanisms, and New Targets
Renato B Pereira1, Nikolai M Evdokimov2, Florence Lefranc3
1REQUIMTE/LAQV, Laboratório de Farmacognosia, Departamento de Química, Faculdade de Farmácia, Universidade do Porto, R. Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal. ren.pereira@gmail.com.
Abstract:
The role of the marine environment in the development of anticancer drugs has been widely reviewed, particularly in recent years. However, the innovation in terms of clinical benefits has not been duly emphasized, although there are important breakthroughs associated with the use of marine-derived anticancer agents that have altered the current paradigm in chemotherapy. In addition, the discovery and development of marine drugs has been extremely rewarding with significant scientific gains, such as the discovery of new anticancer mechanisms of action as well as novel molecular targets. Approximately 50 years since the approval of cytarabine, the marine-derived anticancer pharmaceutical pipeline includes four approved drugs and eighteen agents in clinical trials, six of which are in late development. Thus, the dynamic pharmaceutical pipeline consisting of approved and developmental marine-derived anticancer agents offers new hopes and new tools in the treatment of patients afflicted with previously intractable types of cancer.
Insights
Marine environments yield promising anticancer drugs, offering new hope for intractable cancers. The marine pharmaceutical pipeline includes approved drugs and agents in clinical trials, advancing cancer treatment.
Area of Science:
- Marine biotechnology
- Drug discovery and development
- Oncology
Background:
- The marine environment is a rich source for novel anticancer drug discovery.
- Recent years have seen increased focus on marine-derived anticancer agents.
- Clinical benefits and paradigm shifts in chemotherapy are often overlooked.
Purpose of the Study:
- To highlight the clinical innovations and benefits of marine-derived anticancer agents.
- To emphasize the scientific gains from marine drug discovery, including new mechanisms and targets.
- To provide an overview of the current marine-derived anticancer pharmaceutical pipeline.
Main Methods:
- Review of existing literature on marine-derived anticancer drugs.
- Analysis of the current pharmaceutical pipeline, including approved drugs and clinical trials.
- Assessment of scientific contributions, such as novel mechanisms of action and molecular targets.
Main Results:
- Marine-derived anticancer agents have led to significant breakthroughs in chemotherapy.
- Drug discovery from marine sources has yielded new anticancer mechanisms and molecular targets.
- The current pipeline includes four approved drugs and eighteen agents in clinical trials, with six in late development.
Conclusions:
- The marine pharmaceutical pipeline offers new therapeutic options for difficult-to-treat cancers.
- Marine-derived anticancer agents represent a dynamic and evolving area of cancer treatment.
- These agents provide renewed hope and advanced tools for cancer patients.
Related Concept Videos
Benefits of Self-Esteem
Subviral Agents
Air-entraining Agents
Reaction Mechanisms
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
The Quantum-Mechanical Model of an Atom
Masking and Demasking Agents
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...

